IL-4 subverts mycobacterial containment in Mycobacterium tuberculosis-infected human macrophages

Anil Pooran, Malika Davids, Andrew Nel, Aubrey Shoko, Jonathan Blackburn, Keertan Dheda

Source: Eur Respir J, 54 (2) 1802242; 10.1183/13993003.02242-2018
Journal Issue: August
Disease area: Respiratory infections

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Anil Pooran, Malika Davids, Andrew Nel, Aubrey Shoko, Jonathan Blackburn, Keertan Dheda. IL-4 subverts mycobacterial containment in Mycobacterium tuberculosis-infected human macrophages. Eur Respir J, 54 (2) 1802242; 10.1183/13993003.02242-2018

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
ESAT-6/CFP-10 and PPD-stimulated cytokine production in patients with MTB infection
Source: Annual Congress 2007 - New methods to diagnose tuberculosis infection and disease
Year: 2007



Quantitative T-cell interferon-gamma responses to Mycobacterium tuberculosis-specific antigens in latent and active tuberculosis
Source: Annual Congress 2008 - New tools in tuberculosis diagnosis
Year: 2008

Mycobacterium tuberculosis blocks phagolysosome maturation in alveolar macrophages of tuberculosis patients
Source: International Congress 2018 – The immune response to tuberculosis: development of biomarkers and diagnostic tools
Year: 2018

Pulmonary infection with Mycobacterium avium in immunocompetent children without IFN-γ (interferon-gamma) or IL-12-receptor deficiency
Source: Eur Respir J 2001; 18: Suppl. 33, 511s
Year: 2001

In vitro immune response to Mycobacterium tuberculosis antigens
Source: Eur Respir J 2005; 26: Suppl. 49, 22s
Year: 2005

Mycobacterium tuberculosis modulates mitochondrial function in human macrophages
Source: Virtual Congress 2020 – Non-tuberculous mycobacteria and latent tuberculosis infection
Year: 2020


Mycobacterium tuberculosis modulates mitochondrial function in human macrophages
Source: Virtual Congress 2021 – Advanced in vitro models for drug discovery
Year: 2021


Mycobacterium tuberculosis reside only inside phagosomes in alveolar macrophages of tuberculosis patients
Source: International Congress 2018 – The immune response to tuberculosis: development of biomarkers and diagnostic tools
Year: 2018

Interferon-gamma release assays for the diagnosis of latent Mycobacterium tuberculosis infection
Source: Eur Respir J 2011; 38: 1237-1238
Year: 2011


Deficient interleukin-17 production in response to Mycobacterium abscessus in cystic fibrosis
Source: Eur Respir J 2016; 47: 990-993
Year: 2016


Tuberculosis treatment effect on T-cell interferon-γ responses to Mycobacterium tuberculosis-specific antigens
Source: Eur Respir J 2010; 36: 355
Year: 2010



Interferon-? release assays for the diagnosis of latent Mycobacterium tuberculosis infection
Source: Eur Respir J 2011; 38: 1238-1239
Year: 2011


Increased frequencies of pulmonary regulatory T-cells in latent Mycobacterium tuberculosis infection
Source: Eur Respir J 2012; 40: 1450-1457
Year: 2012



A novel TNF inhibitor does not compromise host immunity to mycobacterium tuberculosis and BCG infections and still protects from hepatitis
Source: Annual Congress 2009 - Clinical immunology of tuberculosis
Year: 2009

Impaired host defense against Mycobacterium avium in mice with chronic granulomatous disease
Source: Annual Congress 2008 - New tests and methods to diagnose tuberculosis infection and disease and to monitor treatment
Year: 2008


Design of immunogenic multiepitopic mycobacterium tuberculosis peptides from genes selected using in vitro models of mycobacterial macrophage infection
Source: Eur Respir J 2007; 30: Suppl. 51, 493s
Year: 2007

Lymphocyte responses to Mycobacterium tuberculosis and Mycobacterium bovis are similar between BCG-vaccinated patients with cystic fibrosis and healthy controls
Source: Virtual Congress 2020 – Microbiology and antimicrobial strategies in cystic fibrosis
Year: 2020


Discriminating active from latent tuberculosis by Mycobacterium tuberculosis (MTB)-peptide specific immunoresponses
Source: Annual Congress 2008 - Priorities for tuberculosis research in Europe: discussing the results of the Tuberculosis Network European Trials Group (TBNET)
Year: 2008


Comparison of T-cell interferon-γ release assay to mycobacterium tuberculosis-specific antigens in patients with active and latent tuberculosis
Source: Annual Congress 2009 - Tuberculosis contact screening
Year: 2009


HIV-1 infection impairs the bronchoalveolar immune response to mycobacteria
Source: Annual Congress 2009 - Tuberculosis and HIV co-infection
Year: 2009